Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 10 of 33 for IBRUTINIB
  1. Ibrutinib is used: to treat people with mantle cell lymphoma (MCL; a fast-growing cancer that begins ... being treated unsuccessfully with 1 or more medications. Ibrutinib is in a class of medications called kinase ...
  2. Advances in Leukemia Research From the National Institutes of Health (National Cancer Institute)  
    National Cancer Institute ... From the National Institutes of Health ... Acute Lymphocytic Leukemia/Statistics and Research ... Acute Lymphocytic Leukemia ... Childhood Leukemia/ ...
  3. ... Several PLCG2 gene mutations have been associated with ibrutinib resistance, which is a condition in which the drug ibrutinib becomes ineffective in people with these mutations. Ibrutinib ...
  4. Advances in Lymphoma Research From the National Institutes of Health (National Cancer Institute)  
    National Cancer Institute ... From the National Institutes of Health ... Lymphoma/Statistics and Research ... Lymphoma ... Hodgkin Lymphoma/Statistics and Research ... Hodgkin ...
  5. Staging Primary CNS Lymphoma From the National Institutes of Health (National Cancer Institute)  
    National Cancer Institute ... From the National Institutes of Health ... Lymphoma/Diagnosis and Tests ... Lymphoma ... Primary central nervous system (CNS) lymphoma treatment ...
  6. National Cancer Institute ... From the National Institutes of Health ... Lymphoma/Treatments and Therapies ... Lymphoma ... Primary central nervous system (CNS) lymphoma treatment ...
  7. General Information about Primary CNS Lymphoma From the National Institutes of Health (National Cancer Institute)  
    National Cancer Institute ... From the National Institutes of Health ... Lymphoma/Specifics ... Lymphoma ... Primary central nervous system (CNS) lymphoma treatment options ...
  8. ... activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of ... CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed ...
  9. National Cancer Institute ... From the National Institutes of Health ... Lymphoma/Treatments and Therapies ... Lymphoma ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, ...
  10. Stages of Adult Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    National Cancer Institute ... From the National Institutes of Health ... Lymphoma/Diagnosis and Tests ... Lymphoma ... Non-Hodgkin lymphoma (NHL) options include chemotherapy, ...
previous · 1 · 2 · 3 · 4 · next